What ethics does a permanent heart pump raise?
LVAD as destination therapy prolongs life in transplant-ineligible heart failure, but it also reshapes dying, consent, and caregiver burden.
Source
Ethical challenges with the left ventricular assist device as a destination therapy
What they did
The authors re-read survival and complication data from LVAD-DT trials (including REMATCH) and organise the ethical issues around informed consent, caregiver effects, and turning the device off near the end of life.
What they found
LVAD-DT is intended to prolong survival and improve quality of life, yet complications and caregiver load can alter the dying trajectory. Consent must protect autonomy. Deactivation to allow death is discussed alongside the idea that withdrawing support can be morally equivalent to never starting it.
The limits
What it doesn't show
This is not a new RCT. REMATCH numbers are cited from prior trials. It does not settle when a particular patient should refuse or deactivate a pump.
Key terms
- LVAD-DT
- Left ventricular assist device used as permanent destination therapy, not as a bridge to transplant.
- Destination therapy
- Long-term mechanical support for people with end-stage heart failure who cannot have a transplant.
- Device deactivation
- Turning the pump off so that death can follow the underlying heart failure.
- Caregiver burden
- The load LVAD-DT places on spouses, children, and others, which belongs in the consent conversation.
Flashcards
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
LVAD-DT is mainly for?
Common questions
Who is LVAD-DT for?
People with chronic end-stage heart failure who are not transplant candidates.
Why is consent harder here?
Benefits, complications, caregiver effects, and later deactivation all have to be understood.
Is turning the pump off unique?
Withdrawal of life support can be treated as morally equivalent to not starting it, but families still face a hard decision.
More on End-of-life ethics